For	O
this	O
study	O
,	O
the	O
L4	O
vertebrae	O
of	O
20	F-NUM
adult	O
male	O
and	O
20	O
female	O
adults	O
were	O
examined	O
.	O

MethodsThe	O
Bedford	O
Breast	O
Cancer	O
database	O
identified	O
232	F-NUM
women	O
who	O
had	O
relapsed	O
between	O
March	O
2000	O
and	O
March	O
2005	O
with	O
loco-regional	O
or	O
distant	O
disease	O
.	O

Patients	O
’	O
age	O
ranged	O
from	O
34	O
to	O
85	O
years	O
(	O
mean	O
62.7±11.2	O
years	O
)	O
,	O
41	O
%	O
were	O
female	O
(	O
n=17	O
)	O
and	O
59	O
%	O
male	O
(	O
n=24	O
)	O
.	O

A	O
total	O
of	O
14	F-NUM
female	O
Sprague-Dawley	O
rats	O
(	O
12	O
months	O
old	O
;	O
CLEA	O
Japan	O
Inc.	O
,	O
Tokyo	O
,	O
Japan	O
)	O
were	O
utilized	O
for	O
the	O
entire	O
study	O
and	O
the	O
cells	O
from	O
at	O
least	O
3	O
animals	O
were	O
applied	O
to	O
each	O
experiment	O
.	O

Based	O
on	O
recent	O
studies	O
,	O
the	O
4	O
pg/ml	O
estradiol	O
level	O
was	O
used	O
to	O
correspond	O
to	O
the	O
postmenopausal	O
levels	O
(	O
midpoint	O
within	O
the	O
observed	O
postmenopausal	O
range	O
,	O
[	O
44	O
]	O
)	O
,	O
while	O
40	O
pg/ml	O
estradiol	O
represents	O
a	O
level	O
associated	O
with	O
the	O
mean	O
of	O
follicular	O
and	O
luteal	O
phases	O
of	O
premenopausal	O
women	O
[	O
45	O
]	O
.	O

A	O
total	O
of	O
148	O
SLE	O
patients	O
(	O
136	F-NUM
females	O
and	O
12	M-NUM
males	O
)	O
were	O
enrolled	O
in	O
the	O
present	O
study	O
.	O

76	O
of	O
the	O
SLE	O
patients	O
were	O
part	O
of	O
54	O
families	O
,	O
from	O
which	O
166	O
relatives	O
(	O
98	F-NUM
females	O
and	O
68	M-NUM
males	O
)	O
were	O
also	O
included	O
in	O
the	O
study	O
.	O

Control	O
individuals	O
(	O
N	O
=	O
117	O
,	O
58	F-NUM
females	O
and	O
59	M-NUM
males	O
)	O
were	O
blood	O
donors	O
recruited	O
from	O
several	O
regional	O
blood	O
centers	O
.	O

Patients	O
with	O
current	O
corticosteroid	O
therapy	O
and/or	O
anti-osteoporotic	O
drugs	O
and/or	O
renal	O
or	O
hepatic	O
dysfunction	O
in	O
the	O
year	O
before	O
onset	O
of	O
the	O
study	O
were	O
excluded	O
too.Hundred	O
and	O
four	O
patients	O
were	O
thus	O
included	O
in	O
the	O
study	O
(	O
95	F-NUM
females	O
,	O
9	M-NUM
males	O
)	O
,	O
mean	O
age	O
was	O
61.4	O
±	O
7.2	O
years	O
.	O

Briefly	O
,	O
the	O
right	O
tibial	O
nerve	O
of	O
18	M-NUM
male	O
Lewis	O
rats	O
(	O
200	O
g	O
each	O
)	O
was	O
transected	O
under	O
inhalational	O
halothane	O
anaesthesia	O
completely	O
denervating	O
the	O
gastrocnemius	O
muscle	O
.	O

Participants	O
were	O
fully	O
apprised	O
of	O
the	O
purpose	O
of	O
the	O
research	O
,	O
assured	O
of	O
confidentiality	O
and	O
asked	O
to	O
provide	O
written	O
informed	O
consent.Four	O
nursing	O
grade	O
focus	O
groups	O
took	O
place	O
(	O
n	O
=	O
18	O
,	O
3	M-NUM
×	O
male	O
,	O
15	F-NUM
×	O
female	O
)	O
.	O

Three	O
medical	O
grade	O
focus	O
groups	O
and	O
one	O
in-depth	O
interview	O
took	O
place	O
(	O
n	O
=	O
12	O
,	O
7	M-NUM
×	O
male	O
,	O
5	F-NUM
×	O
female	O
)	O
.	O

In	O
this	O
analysis	O
,	O
we	O
included	O
121	O
216	O
women	O
who	O
were	O
California	O
residents	O
,	O
were	O
under	O
the	O
age	O
of	O
85	O
years	O
at	O
baseline	O
and	O
had	O
no	O
prior	O
history	O
of	O
a	O
haematopoietic	O
malignancy	O
.	O

(	O
b	O
)	O
Pigment	O
colour	O
measurementEmpirical	O
measurements	O
of	O
the	O
impact	O
of	O
oxygenated	O
and	O
deoxygenated	O
blood	O
on	O
skin	O
colour	O
were	O
made.Deoxygenated	O
blood10	O
further	O
participants	O
(	O
5	F-NUM
male	O
,	O
5	O
female	O
;	O
aged	O
24–35	O
)	O
were	O
recruited	O
.	O

The	O
elevated	O
blood	O
content	O
of	O
the	O
lowered	O
arm	O
is	O
due	O
largely	O
to	O
deoxygenated	O
blood	O
[	O
33	O
]	O
.Oxygenated	O
blood10	O
further	O
participants	O
(	O
2	M-NUM
male	O
,	O
8	F-NUM
female	O
;	O
aged	O
19–25	O
)	O
were	O
recruited	O
.	O

Each	O
participant	O
saw	O
each	O
of	O
the	O
51	O
faces	O
once	O
in	O
the	O
two	O
dimensional	O
trials.For	O
the	O
cross-cultural	O
study	O
,	O
single-axis	O
CIELab	O
a	O
*	O
transformation	O
trials	O
were	O
presented	O
to	O
black	O
South	O
African	O
(	O
10	F-NUM
male	O
,	O
10	O
female	O
;	O
aged	O
19–29	O
)	O
and	O
Caucasian	O
UK-based	O
(	O
7	O
male	O
,	O
11	O
female	O
;	O
aged	O
18–34	O
)	O
participants	O
.	O

173	M-NUM
patients	O
were	O
male	O
,	O
123	F-NUM
were	O
female	O
(	O
ratio	O
male/female	O
1.41	O
)	O
.	O

To	O
be	O
included	O
in	O
the	O
GOOD	O
Study	O
,	O
subjects	O
had	O
to	O
be	O
male	O
,	O
18	O
to	O
20	O
years	O
of	O
age	O
,	O
and	O
willing	O
to	O
participate	O
in	O
the	O
study	O
.	O

The	O
patients	O
included	O
91	M-NUM
men	O
and	O
23	F-NUM
women	O
.	O

(	O
1991	O
)	O
:	O
where	O
sex	O
corresponds	O
to	O
females	O
=	O
0	O
,	O
and	O
males	O
=	O
1	O
.	O

Twenty-nine	O
knees	O
from	O
29	O
patients	O
aged	O
14	O
to	O
49	O
years	O
(	O
21	M-NUM
males	O
and	O
8	F-NUM
females	O
)	O
were	O
used	O
as	O
the	O
source	O
of	O
these	O
cells	O
.	O

Normal	O
(	O
Rest	O
of	O
the	O
body	O
)	O
CompartmentThe	O
entire	O
body	O
of	O
a	O
70	O
kg	O
man	O
minus	O
the	O
blood	O
would	O
weigh	O
about	O
65	O
kg	O
.	O

DNA	O
and	O
plasma	O
samples	O
of	O
72	O
early-onset	O
probable	O
Alzheimer	O
's	O
disease	O
patients	O
(	O
mean	O
age	O
at	O
onset	O
±	O
SD	O
:	O
57.9	O
±	O
6.4	O
years	O
;	O
range	O
:	O
37–65	O
years	O
;	O
61	F-NUM
%	O
women	O
)	O
and	O
70	O
unrelated	O
control	O
individuals	O
(	O
mean	O
age	O
±	O
SD	O
:	O
66.3	O
±	O
11.0	O
years	O
;	O
range	O
:	O
46–85	O
years	O
;	O
50	O
%	O
women	O
)	O
were	O
also	O
ascertained	O
at	O
Mayo	O
Jacksonville	O
.	O

The	O
941	O
control	O
subjects	O
were	O
selected	O
on	O
fasting	O
plasma	O
glucose	O
<	O
6.1	O
mmol/l	O
and	O
BMI	O
<	O
27	O
kg/m2	O
(	O
N	O
=	O
380	M-NUM
males	O
and	O
561	F-NUM
females	O
,	O
age	O
at	O
examination	O
62.2.0	O
±	O
7.5	O
years	O
,	O
BMI	O
23.2	O
±	O
2.0	O
kg/m2	O
)	O
and	O
all	O
were	O
unrelated	O
.	O

Materials	O
and	O
MethodsParticipantsThirty-one	O
subjects	O
between	O
the	O
ages	O
of	O
18	O
and	O
30	O
were	O
assigned	O
to	O
either	O
a	O
Nap	O
group	O
(	O
n	O
=	O
15	O
;	O
7	M-NUM
males	O
,	O
mean	O
age	O
24.3	O
[	O
SD	O
±	O
2.0	O
]	O
)	O
or	O
No-Nap	O
group	O
(	O
n=16	O
,	O
8	O
males	O
,	O
mean	O
age	O
23.1	O
[	O
SD	O
±	O
1.4	O
]	O
)	O
.	O

MethodsSubjects24	O
(	O
12	F-NUM
female	O
,	O
12	O
male	O
)	O
native	O
German	O
subjects	O
of	O
Western-	O
or	O
Middle	O
European	O
descent	O
participated	O
in	O
the	O
study	O
.	O

MethodsPatientsFor	O
proteomic	O
analyses	O
duodenal	O
biopsies	O
were	O
selected	O
from	O
five	O
adult	O
subjects	O
,	O
3	M-NUM
males	O
and	O
2	F-NUM
females	O
,	O
between	O
the	O
ages	O
of	O
19	O
and	O
42	O
,	O
on	O
their	O
first	O
visit	O
for	O
a	O
suspected	O
diagnosis	O
of	O
CD	O
,	O
attending	O
the	O
Gastroenterology	O
Unit	O
of	O
the	O
Centro	O
di	O
Riferimento	O
Oncologico	O
,	O
IRCCS	O
.	O

Three	O
lean	O
(	O
BMI	O
<	O
25	O
kg/m2	O
)	O
and	O
five	O
obese	O
(	O
BMI	O
>	O
30	O
kg/m2	O
)	O
male	O
subjects	O
participated	O
in	O
this	O
study	O
.	O

In	O
1999	O
,	O
the	O
focus	O
was	O
found	O
to	O
be	O
hyperendemic	O
during	O
a	O
rapid	O
assessment	O
of	O
30	M-NUM
men	O
aged	O
more	O
than	O
19	O
years	O
in	O
each	O
village	O
:	O
75	O
,	O
86	O
and	O
93	O
%	O
nodule	O
carriers	O
and	O
80	O
,	O
89	O
and	O
90	O
%	O
mf	O
carriers	O
were	O
found	O
(	O
R.	O
Horstmann	O
,	O
Bernhard	O
Nocht	O
Institute	O
,	O
personal	O
communication	O
)	O
.	O

In	O
total	O
,	O
66	O
European	O
citizens	O
took	O
part	O
,	O
34	M-NUM
men	O
and	O
32	F-NUM
women	O
.	O

A	O
total	O
of	O
18	O
family	O
members	O
(	O
12	F-NUM
women	O
and	O
6	M-NUM
men	O
)	O
ranging	O
in	O
age	O
from	O
7	O
to	O
90	O
years	O
were	O
analyzed	O
.	O

We	O
studied	O
medical	O
records	O
on	O
118	M-NUM
male	O
and	O
91	F-NUM
female	O
patients	O
,	O
mean	O
age	O
of	O
55.6	O
years	O
.	O

The	O
human	O
genome	O
GeneChip	O
U133A	O
consisting	O
of	O
more	O
than	O
22000	O
probe	O
sets	O
was	O
used	O
for	O
this	O
study.A	O
group	O
of	O
8	O
primary	O
pterygium	O
samples	O
,	O
harvested	O
from	O
4	F-NUM
males	O
(	O
aged	O
40	O
to	O
50	O
years	O
old	O
)	O
and	O
4	O
females	O
(	O
aged	O
50	O
to	O
60	O
years	O
old	O
)	O
was	O
used	O
in	O
this	O
experiment	O
.	O

RESEARCH	O
DESIGN	O
AND	O
METHODSA	O
total	O
of	O
11	O
individuals	O
(	O
5	M-NUM
men	O
,	O
6	F-NUM
women	O
,	O
aged	O
[	O
mean	O
±	O
SD	O
]	O
34.8	O
±	O
8.9	O
years	O
,	O
BMI	O
24.2	O
±	O
3.4	O
kg/m2	O
)	O
with	O
type	O
1	O
diabetes	O
for	O
15.9	O
±	O
9.5	O
years	O
participated	O
in	O
the	O
study	O
.	O

For	O
the	O
diet-induced	O
obesity	O
(	O
DIO	O
)	O
model	O
,	O
we	O
randomized	O
10	M-NUM
6-week-old	O
male	O
C57BL/6J	O
littermates	O
to	O
either	O
normal	O
diet	O
or	O
high-fat	O
diet	O
(	O
55	O
%	O
fat	O
,	O
Teklad	O
)	O
.	O

MethodsWe	O
collected	O
at	O
autopsy	O
36	F-NUM
human	O
female	O
fetuses	O
at	O
different	O
gestational	O
ages	O
,	O
that	O
did	O
not	O
displayed	O
any	O
visible	O
alteration	O
of	O
the	O
pelvic	O
organs	O
.	O

MethodsParticipantsTwenty-eight	O
healthy	O
,	O
right-handed	O
adults	O
without	O
subjective	O
hearing	O
impairment	O
were	O
included	O
(	O
15	M-NUM
men	O
,	O
13	F-NUM
women	O
,	O
mean	O
age	O
=	O
40	O
years	O
,	O
age	O
range	O
=	O
20	O
–	O
78	O
years	O
)	O
.	O

The	O
neurobehavioral	O
groups	O
consisted	O
of	O
28	O
non-Korsakoff	O
alcoholics	O
(	O
21	M-NUM
men	O
,	O
7	F-NUM
women	O
)	O
,	O
9	O
alcoholic	O
KS	O
patients	O
(	O
8	O
men	O
,	O
1	O
woman	O
)	O
;	O
4	O
patients	O
(	O
all	O
women	O
)	O
with	O
ruptured	O
and	O
repaired	O
ACoA	O
aneurysms	O
;	O
and	O
18	O
patients	O
with	O
PD	O
(	O
12	O
men	O
,	O
6	O
women	O
)	O
.	O

Seventy	O
neurologically	O
intact	O
control	O
participants	O
(	O
NC	O
;	O
22	M-NUM
men	O
,	O
48	F-NUM
women	O
)	O
also	O
were	O
included	O
.	O

Eight	O
of	O
the	O
PD	O
patients	O
had	O
experienced	O
initial	O
motor	O
symptoms	O
on	O
the	O
left	O
side	O
of	O
the	O
body	O
(	O
LPD	O
;	O
6	M-NUM
men	O
)	O
,	O
and	O
10	O
first	O
experienced	O
symptoms	O
on	O
the	O
right	O
(	O
RPD	O
;	O
6	O
men	O
)	O
.	O

They	O
were	O
compared	O
with	O
seven	O
neurologically	O
healthy	O
NC	O
participants	O
(	O
3	M-NUM
men	O
,	O
4	F-NUM
women	O
)	O
.	O

Materials	O
and	O
MethodsParticipantsTwenty-three	O
healthy	O
right-handed	O
Italian	O
University	O
students	O
(	O
12	M-NUM
males	O
and	O
11	F-NUM
females	O
)	O
were	O
recruited	O
for	O
this	O
experiment	O
.	O

Eight	O
control	O
small	O
bowel	O
specimens	O
were	O
taken	O
from	O
eight	O
non-obese	O
patients	O
(	O
4	F-NUM
female	O
,	O
4	O
male	O
)	O
undergoing	O
either	O
small	O
bowel	O
resection	O
for	O
benign	O
disease	O
(	O
five	O
patients	O
)	O
or	O
formation	O
of	O
an	O
ileal	O
pouch-anal	O
anastomosis	O
(	O
three	O
patients	O
)	O
.	O

PATIENTS	O
AND	O
METHODSPatients	O
and	O
samplesSamples	O
of	O
peripheral	O
blood	O
and	O
synovial	O
fluid	O
from	O
36	O
children	O
(	O
28	O
females	O
and	O
8	O
males	O
)	O
who	O
met	O
the	O
International	O
League	O
of	O
Associations	O
for	O
Rheumatology	O
criteria	O
for	O
JIA	O
(	O
30	O
)	O
and	O
11	O
healthy	O
controls	O
(	O
7	F-NUM
females	O
and	O
4	M-NUM
males	O
)	O
were	O
included	O
in	O
the	O
study	O
.	O

The	O
CB/Pneumonia	O
group	O
(	O
n	O
=	O
20	O
)	O
included	O
10	F-NUM
men	O
and	O
10	O
women	O
aged	O
66.8	O
±	O
9.5	O
years	O
.	O

Mean	O
age	O
for	O
the	O
conventional	O
group	O
was	O
61.8	O
years	O
(	O
range	O
31	O
to	O
85	O
)	O
for	O
13	F-NUM
women	O
and	O
10	M-NUM
men	O
.	O

For	O
LC	O
,	O
mean	O
age	O
was	O
55.5	O
years	O
(	O
range	O
28	O
to	O
82	O
)	O
;	O
this	O
group	O
consisted	O
of	O
13	F-NUM
women	O
and	O
8	M-NUM
men	O
.	O

Twenty	O
healthy	O
persons	O
,	O
consisting	O
of	O
laboratory	O
personnel	O
and	O
blood	O
volunteer	O
donors	O
(	O
10	F-NUM
females	O
and	O
10	O
males	O
)	O
,	O
corresponding	O
by	O
age	O
and	O
sexes	O
to	O
the	O
examined	O
patients	O
groups	O
were	O
also	O
studied.2.2	O
.	O

METHODSSubjectsFourteen	O
subjects	O
(	O
9	F-NUM
female	O
and	O
5	M-NUM
male	O
,	O
10	O
right-handed	O
)	O
between	O
21	O
and	O
36	O
years	O
old	O
(	O
mean	O
24.5	O
)	O
took	O
part	O
in	O
the	O
experiment	O
.	O

MethodsParticipantsParticipants	O
were	O
10	F-NUM
females	O
aged	O
18-65	O
with	O
no	O
history	O
of	O
weight	O
loss	O
surgery	O
or	O
current	O
dieting	O
.	O

Of	O
the	O
AML	O
patients	O
,	O
17	M-NUM
males	O
and	O
6	F-NUM
females	O
were	O
included	O
,	O
with	O
ages	O
ranging	O
from	O
26	O
to	O
78	O
yr	O
,	O
at	O
a	O
median	O
age	O
of	O
45.61	O
(	O
SD	O
,	O
15.56	O
)	O
yr.	O
Of	O
the	O
CML	O
patients	O
,	O
11	O
males	O
and	O
10	O
females	O
were	O
included	O
,	O
with	O
ages	O
ranging	O
from	O
18	O
to	O
75	O
yr	O
(	O
mean±SD	O
,	O
49.91±16.53	O
)	O
.	O

As	O
controls	O
,	O
22	O
normal	O
peripheral	O
bloods	O
were	O
obtained	O
from	O
healthy	O
volunteers	O
(	O
11	M-NUM
males	O
and	O
10	F-NUM
females	O
)	O
ranging	O
from	O
20	O
to	O
78	O
yr	O
of	O
age	O
(	O
mean±SD	O
,	O
45.36±20.64	O
)	O
.Sodium	O
bisulfite	O
treatment	O
and	O
MSPChemical	O
modification	O
was	O
performed	O
as	O
described	O
previously	O
,	O
with	O
minor	O
modifications	O
(	O
19	O
)	O
.	O

The	O
human	O
osteosarcoma	O
cell	O
line	O
,	O
NOS-1	O
,	O
which	O
is	O
osteoid	O
inducible	O
in	O
xenografted	O
tumors	O
in	O
nude	O
mice	O
,	O
was	O
established	O
previously	O
from	O
a	O
16	O
year-old	O
male	O
Japanese	O
patient	O
[	O
29,30	O
]	O
.	O

MethodsMethods	O
for	O
Measuring	O
TauSubjects	O
(	O
n	O
=	O
60	O
,	O
29	M-NUM
male	O
,	O
mean	O
age±SD	O
26.33±5.48	O
years	O
)	O
maintained	O
a	O
regular	O
sleep	O
schedule	O
at	O
home	O
for	O
1	O
week	O
before	O
coming	O
to	O
the	O
laboratory	O
for	O
a	O
5-day	O
session	O
.	O

Thus	O
29	O
patients	O
,	O
19	M-NUM
males	O
and	O
10	F-NUM
females	O
,	O
completed	O
the	O
study	O
.	O

One	O
of	O
the	O
controls	O
was	O
excluded	O
because	O
of	O
intake	O
of	O
NSAIDs	O
meaning	O
that	O
a	O
total	O
of	O
29	O
controls	O
,	O
19	M-NUM
males	O
and	O
10	F-NUM
females	O
,	O
completed	O
the	O
study	O
.	O

Materials	O
and	O
MethodsSamplesAll	O
193	M-NUM
male	O
Caucasian	O
schizophrenic	O
patients	O
met	O
criteria	O
for	O
the	O
disease	O
as	O
defined	O
by	O
the	O
Diagnostic	O
and	O
Statistical	O
Manual	O
,	O
Fourth	O
Edition	O
,	O
Revised	O
(	O
DSM-IV-R	O
)	O
,	O
as	O
described	O
previously	O
[	O
27	O
]	O
.	O

One	O
group	O
of	O
14	O
lower	O
eyelids	O
of	O
7	O
cadavers	O
(	O
7	O
right	O
,	O
7	O
left	O
;	O
3	M-NUM
males	O
,	O
4	F-NUM
females	O
)	O
with	O
an	O
average	O
age	O
at	O
death	O
of	O
80.4	O
years	O
(	O
range	O
:	O
73~97	O
)	O
,	O
were	O
sagittally	O
incised	O
from	O
the	O
lower	O
lacrimal	O
punctum	O
(	O
Figure	O
1	O
)	O
.	O

RESEARCH	O
DESIGN	O
AND	O
METHODSA	O
total	O
of	O
13	F-NUM
women	O
and	O
8	M-NUM
men	O
participated	O
in	O
the	O
first	O
study	O
(	O
lipid	O
study	O
)	O
.	O

The	O
13	O
healthy	O
young	O
women	O
had	O
regular	O
menstrual	O
cycles	O
.	O

Informed	O
written	O
consent	O
was	O
obtained	O
from	O
each	O
participant.For	O
the	O
second	O
human	O
trial	O
(	O
PPARγ	O
study	O
)	O
7	M-NUM
male	O
and	O
10	F-NUM
female	O
volunteers	O
with	O
impaired	O
glucose	O
tolerance	O
were	O
investigated	O
in	O
a	O
prospective	O
trial	O
.	O

To	O
avoid	O
interactions	O
between	O
the	O
study	O
procedures	O
,	O
the	O
study	O
was	O
performed	O
at	O
intervals	O
of	O
at	O
least	O
2	O
days	O
in	O
men	O
.	O

Of	O
the	O
remaining	O
584	O
patients	O
who	O
attempted	O
suicide	O
,	O
38.2	O
%	O
(	O
n	O
=	O
223	M-NUM
)	O
were	O
male	O
and	O
61.8	O
%	O
(	O
n	O
=	O
361	F-NUM
)	O
were	O
female	O
,	O
with	O
an	O
age	O
ranged	O
of	O
14	O
to	O
88	O
years	O
and	O
a	O
mean	O
of	O
38.0	O
years	O
,	O
standard	O
deviation	O
15.9	O
years	O
(	O
M	O
=	O
41.1	O
,	O
SD	O
=	O
15.9	O
years	O
for	O
males	O
;	O
M	O
=	O
36.2	O
,	O
SD	O
=	O
15.5	O
years	O
for	O
females	O
)	O
.	O

MethodsPatientsThe	O
investigation	O
has	O
been	O
performed	O
on	O
formalin-fixed	O
and	O
paraffin-embedded	O
testis	O
tissues	O
from	O
16	M-NUM
male	O
patients	O
(	O
ages	O
20	O
–	O
35	O
years	O
)	O
with	O
pure	O
seminoma	O
(	O
n	O
=	O
10	O
)	O
and	O
pure	O
embryonal	O
carcinoma	O
(	O
n	O
=	O
5	O
)	O
undergoing	O
to	O
therapeutic	O
orchidectomy	O
.	O

Control	O
testicular	O
tissues	O
were	O
obtained	O
from	O
2	M-NUM
male	O
patients	O
(	O
ages	O
29	O
and	O
35	O
years	O
)	O
showing	O
testes	O
with	O
a	O
like-Sarcoidosis	O
granulomatous	O
lesion	O
.	O

The	O
entire	O
association	O
cohort	O
across	O
all	O
phenotypes	O
consisted	O
of	O
957	O
individuals	O
,	O
781	M-NUM
women	O
and	O
176	F-NUM
men	O
.	O

The	O
control	O
group	O
was	O
comprised	O
of	O
710	O
randomly	O
collected	O
individuals	O
from	O
the	O
general	O
population	O
,	O
468	F-NUM
women	O
and	O
242	M-NUM
men	O
,	O
in	O
the	O
age	O
range	O
of	O
30–85	O
y	O
,	O
whose	O
medical	O
history	O
was	O
unknown	O
.	O

Fifteen	O
young	O
adults	O
(	O
7	M-NUM
males	O
,	O
8	F-NUM
females	O
,	O
mean	O
age	O
=	O
23.0	O
years	O
old	O
,	O
S.D	O
.	O

Twelve	O
healthy	O
elderly	O
adults	O
(	O
5	M-NUM
males	O
,	O
7	F-NUM
females	O
,	O
mean	O
age	O
=	O
74.9	O
years	O
old	O
,	O
S.D	O
.	O

This	O
subgroup	O
,	O
hereafter	O
referred	O
to	O
as	O
the	O
“	O
oldest-old	O
”	O
comparison	O
group	O
,	O
consisted	O
of	O
1	M-NUM
male	O
and	O
5	F-NUM
females	O
,	O
with	O
a	O
mean	O
age	O
of	O
82.3	O
years	O
(	O
SD	O
=	O
3.9	O
)	O
,	O
and	O
a	O
mean	O
of	O
10.5	O
years	O
of	O
education	O
(	O
SD	O
=	O
1.4	O
)	O
.	O

In	O
our	O
model	O
when	O
SrAp	O
die	O
they	O
are	O
always	O
replaced	O
,	O
this	O
is	O
most	O
likely	O
not	O
true	O
,	O
but	O
since	O
the	O
number	O
of	O
SrAp	O
in	O
older	O
individuals	O
is	O
no	O
less	O
than	O
a	O
third	O
the	O
number	O
in	O
younger	O
men	O
[	O
49	O
]	O
,	O
we	O
do	O
not	O
believe	O
including	O
this	O
further	O
complication	O
would	O
appreciably	O
affect	O
the	O
model	O
results	O
.	O

A	O
total	O
of	O
121	F-NUM
women	O
were	O
enrolled	O
in	O
the	O
long	O
protocol	O
group	O
.	O

In	O
total	O
,	O
there	O
are	O
1,172	O
smokers	O
,	O
among	O
whom	O
542	M-NUM
are	O
males	O
and	O
630	F-NUM
females	O
.	O

The	O
entire	O
ECTIM	O
study	O
comprised	O
1,332	O
MI	O
patients	O
and	O
1,490	O
controls	O
(	O
62	M-PER
%	O
from	O
UK	O
,	O
21	F-PER
%	O
female	O
)	O
.	O

For	O
the	O
SIPLAC	O
sub-study	O
,	O
cases	O
with	O
MI	O
and	O
a	O
parental	O
history	O
of	O
MI	O
(	O
n	O
=	O
312	F-NUM
,	O
35	O
%	O
females	O
,	O
mean	O
age	O
:	O
56	O
±	O
16	O
years	O
)	O
and	O
controls	O
without	O
CAD	O
and	O
without	O
parental	O
history	O
of	O
MI	O
(	O
n	O
=	O
317	O
,	O
42	O
%	O
females	O
,	O
mean	O
age	O
:	O
59	O
±	O
15	O
years	O
)	O
were	O
selected	O
from	O
the	O
samples	O
recruited	O
in	O
Belfast	O
and	O
Glasgow	O
.	O

Briefly	O
,	O
between	O
November	O
1996	O
and	O
June	O
2000	O
,	O
1,303	O
CAD	O
patients	O
(	O
75	M-PER
%	O
males	O
,	O
mean	O
age	O
:	O
61.7	O
±	O
0.3	O
years	O
)	O
were	O
recruited	O
at	O
the	O
Department	O
of	O
Medicine	O
II	O
of	O
the	O
Johannes	O
Gutenberg	O
University	O
Mainz	O
and	O
the	O
Bundeswehrzentralkrankenhaus	O
Koblenz	O
at	O
the	O
occasion	O
of	O
a	O
diagnostic	O
coronary	O
angiography	O
.	O

Healthy	O
control	O
subjects	O
(	O
n	O
=	O
484	M-NUM
,	O
73	O
%	O
males	O
,	O
mean	O
age	O
60.0	O
±	O
0.4	O
years	O
)	O
were	O
recruited	O
either	O
from	O
general	O
practitioners	O
’	O
offices	O
in	O
the	O
course	O
of	O
a	O
routine	O
check-up	O
or	O
by	O
newspaper	O
announcement	O
.	O

Twelve	O
knees	O
of	O
twelve	O
fresh	O
,	O
frozen	O
,	O
whole	O
human	O
cadavers	O
(	O
5	M-NUM
males	O
,	O
7	F-NUM
females	O
;	O
mean	O
age	O
79.2	O
,	O
range	O
47-95	O
y/o	O
)	O
were	O
tested	O
.	O

There	O
were	O
17	O
patients	O
(	O
10	M-NUM
male	O
,	O
7	F-NUM
female	O
)	O
from	O
1997	O
to	O
2005	O
who	O
participated	O
in	O
the	O
study	O
.	O

Participants	O
were	O
randomly	O
assigned	O
to	O
either	O
the	O
test	O
(	O
6	F-NUM
men	O
and	O
6	O
women	O
;	O
age	O
:	O
mean	O
=	O
27.0	O
years	O
,	O
SEM	O
=	O
2.77	O
years	O
)	O
or	O
the	O
control	O
(	O
5	O
men	O
and	O
7	O
women	O
;	O
age	O
:	O
mean	O
=	O
24.6	O
years	O
,	O
SEM	O
=	O
1.39	O
years	O
)	O
group	O
.	O

in	O
1975	O
from	O
tumor	O
tissue	O
of	O
the	O
pancreas	O
obtained	O
from	O
a	O
65-year-old	O
Caucasian	O
male	O
[	O
18	O
]	O
.	O

Peptides	O
were	O
radio-labeled	O
with	O
the	O
chloramine	O
T	O
method	O
as	O
described	O
[	O
31	O
]	O
.Characteristics	O
of	O
study	O
populationHealthy	O
males	O
and	O
females	O
between	O
18	O
and	O
59	O
years	O
of	O
age	O
were	O
used	O
in	O
this	O
study	O
.	O

Biological	O
data	O
on	O
TH	O
and	O
OC	O
concentrations	O
were	O
available	O
for	O
204	F-NUM
pregnant	O
women	O
.	O

Rather	O
than	O
'lose	O
'	O
these	O
patients	O
we	O
agreed	O
to	O
treat	O
most	O
of	O
them	O
from	O
the	O
start	O
with	O
the	O
fully	O
'active	O
'	O
radiator.A	O
total	O
of	O
10	O
patients	O
(	O
median	O
age	O
62	O
years	O
,	O
range	O
34	O
years	O
to	O
83	O
years	O
)	O
,	O
5	F-NUM
males	O
and	O
5	O
females	O
,	O
received	O
a	O
total	O
of	O
285	O
treatments	O
.	O

Written	O
informed	O
consent	O
was	O
taken	O
from	O
the	O
families	O
of	O
cornea	O
donors	O
(	O
14	F-NUM
males	O
and	O
14	O
females	O
;	O
mean	O
age	O
31.9	O
±	O
8.6	O
;	O
age	O
range	O
19–48	O
years	O
)	O
.	O

MATERIALS	O
AND	O
METHODSParticipantsInformed	O
consent	O
was	O
obtained	O
from	O
thirteen	O
healthy	O
righthanded	O
participants	O
(	O
7	F-NUM
female	O
,	O
age	O
range	O
19–33	O
,	O
mean	O
age=22.7	O
,	O
recruited	O
by	O
advertisement	O
)	O
.	O

The	O
children	O
subjects	O
(	O
10	M-NUM
males	O
,	O
13	F-NUM
females	O
)	O
ranged	O
in	O
age	O
from	O
7	O
to	O
9	O
y	O
(	O
mean	O
age	O
7.95	O
y	O
)	O
with	O
an	O
IQ	O
range	O
of	O
88	O
to	O
137	O
(	O
mean	O
IQ	O
:	O
112	O
)	O
;	O
the	O
young-adult	O
subjects	O
(	O
11	O
males	O
,	O
11	O
females	O
)	O
ranged	O
in	O
age	O
from	O
19	O
to	O
22	O
y	O
(	O
mean	O
age	O
20.4	O
y	O
)	O
with	O
an	O
IQ	O
range	O
of	O
97	O
to	O
137	O
(	O
mean	O
IQ	O
:	O
112	O
)	O
.	O

Eleven	O
subjects	O
(	O
5	F-NUM
females	O
,	O
ages	O
25–41	O
years	O
)	O
took	O
part	O
in	O
the	O
pre-scan	O
behavioral	O
measurements	O
.	O

Twelve	O
subjects	O
(	O
6	F-NUM
females	O
,	O
ages	O
28–36	O
years	O
)	O
participated	O
in	O
the	O
original	O
fMRI	O
experiment	O
.	O

Six	O
subjects	O
(	O
4	F-NUM
females	O
,	O
ages	O
23–36	O
years	O
)	O
participated	O
in	O
the	O
control	O
experiment	O
(	O
3	O
of	O
them	O
had	O
also	O
taken	O
part	O
in	O
the	O
original	O
experiment	O
)	O
.	O

Materials	O
and	O
MethodsParadigm	O
DesignTwenty-one	O
volunteers	O
,	O
11	M-NUM
males	O
,	O
between	O
the	O
ages	O
of	O
22	O
and	O
38	O
participated	O
.	O

There	O
were	O
52	O
faces	O
(	O
26	M-NUM
male	O
)	O
from	O
52	O
individuals	O
in	O
each	O
of	O
the	O
4	O
face	O
conditions	O
(	O
each	O
individual	O
's	O
face	O
has	O
both	O
an	O
emotional	O
and	O
a	O
neutral	O
version	O
)	O
,	O
selected	O
from	O
Karolinska	O
directed	O
emotional	O
faces	O
(	O
Lundqvist	O
et	O
al	O
.	O

MethodsParticipantsTwenty-nine	O
university	O
students	O
(	O
13	M-NUM
males	O
and	O
16	F-NUM
females	O
)	O
ranging	O
in	O
age	O
from	O
20	O
to	O
30	O
years	O
(	O
mean	O
age	O
=	O
23	O
years	O
)	O
took	O
part	O
in	O
this	O
experiment	O
as	O
volunteers	O
.	O

There	O
were	O
117	M-NUM
males	O
(	O
45	O
%	O
)	O
and	O
141	F-NUM
females	O
(	O
55	O
%	O
)	O
in	O
this	O
study	O
.	O

A	O
total	O
of	O
669	O
patients	O
with	O
clinically	O
manifested	O
asthma	O
,	O
317	M-NUM
males	O
and	O
352	F-NUM
females	O
were	O
recruited	O
from	O
Weifang	O
Asthma	O
Hospital	O
and	O
Shandong	O
Provincial	O
Hospital	O
from	O
2004	O
to	O
2009	O
.	O

Unrelated	O
,	O
random-sampled	O
controls	O
,	O
349	M-NUM
males	O
and	O
362	F-NUM
females	O
had	O
no	O
symptoms	O
of	O
any	O
atopic	O
,	O
lung	O
and	O
skin	O
diseases	O
and	O
had	O
no	O
familial	O
history	O
of	O
asthma/atopy	O
.	O

Genomic	O
DNA	O
was	O
extracted	O
from	O
formalin-fixed	O
and	O
paraffin-embedded	O
tissue	O
(	O
7	O
out	O
of	O
59	O
)	O
,	O
from	O
fresh-frozen	O
tissue	O
(	O
18	O
out	O
of	O
59	O
)	O
,	O
and	O
from	O
leukemic	O
blood	O
specimens	O
(	O
34	O
out	O
of	O
59	O
)	O
as	O
previously	O
described	O
[	O
16	O
,	O
18	O
]	O
.Among	O
these	O
59	O
MCL	O
patients	O
,	O
47	M-NUM
were	O
male	O
and	O
12	F-NUM
female	O
.	O

Disease	O
duration	O
(	O
months	O
)	O
108	O
(	O
1	O
to	O
464	O
)	O
Japanese	O
Age	O
(	O
years	O
)	O
56	O
(	O
24	O
to	O
76	O
)	O
Female	O
sex20	O
(	O
95	O
%	O
)	O
CCP2n.d	O
.	O

Seventeen	O
donors	O
were	O
classified	O
as	O
normal	O
(	O
mean	O
±	O
standard	O
deviation	O
age	O
38.8	O
±	O
16.3	O
years	O
;	O
range	O
14	O
to	O
61	O
years	O
;	O
6	F-NUM
females	O
and	O
11	M-NUM
males	O
)	O
and	O
23	O
donors	O
with	O
OA	O
(	O
mean	O
age	O
of	O
64.7	O
±	O
13.9	O
years	O
;	O
range	O
39	O
to	O
88	O
years	O
;	O
11	O
females	O
and	O
12	O
males	O
)	O
.	O

In	O
brief	O
,	O
ten	O
healthy	O
adult	O
subjects	O
(	O
5	F-NUM
males	O
and	O
5	O
females	O
;	O
ages	O
18–35	O
)	O
were	O
scanned	O
three	O
times	O
in	O
a	O
one	O
week	O
period	O
,	O
except	O
for	O
two	O
females	O
whose	O
third	O
scan	O
was	O
4	O
weeks	O
later	O
at	O
the	O
same	O
phase	O
of	O
the	O
menstrual	O
cycle	O
.	O

